These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9587036)

  • 61. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
    Woo KS; Chook P; Lolin YI; Cheung AS; Chan LT; Sun YY; Sanderson JE; Metreweli C; Celermajer DS
    Circulation; 1997 Oct; 96(8):2542-4. PubMed ID: 9355891
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Coagulation and fibrinolytic systems and atherogenesis].
    Takeya H; Suzuki K
    Nihon Rinsho; 1993 Aug; 51(8):1998-2003. PubMed ID: 8411663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
    Kaul S; Zadeh AA; Shah PK
    J Am Coll Cardiol; 2006 Sep; 48(5):914-23. PubMed ID: 16949480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Annexin II and regulation of cell surface fibrinolysis.
    Hajjar KA; Acharya SS
    Ann N Y Acad Sci; 2000 May; 902():265-71. PubMed ID: 10865846
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The vascular endothelium: physiopathology and participation in thrombogenesis].
    Chordá C; Páramo JA
    Sangre (Barc); 1995 Dec; 40(6):491-8. PubMed ID: 8850233
    [No Abstract]   [Full Text] [Related]  

  • 67. Homocysteine. The association with atherosclerotic vascular disease in older persons.
    Aronow WS
    Geriatrics; 2003 Sep; 58(9):22-4, 27-8. PubMed ID: 14518174
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.
    Selwyn AP; Kinlay S; Creager M; Libby P; Ganz P
    Am J Cardiol; 1997 Mar; 79(5A):17-23. PubMed ID: 9127617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
    John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
    Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.
    Baragetti I; Raselli S; Stucchi A; Terraneo V; Furiani S; Buzzi L; Garlaschelli K; Alberghini E; Catapano AL; Buccianti G
    Nephrol Dial Transplant; 2007 Nov; 22(11):3292-7. PubMed ID: 17595187
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
    Woo KS; Chook P; Lolin YI; Sanderson JE; Metreweli C; Celermajer DS
    J Am Coll Cardiol; 1999 Dec; 34(7):2002-6. PubMed ID: 10588216
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Homocysteine, a risk factor of atherosclerosis].
    Ambrosi P; Rolland P; Garçon D
    Arch Mal Coeur Vaiss; 1996 Dec; 89(12):1667-71. PubMed ID: 9137733
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
    Lip GY; Blann AD
    Ann Med; 2004; 36(2):119-25. PubMed ID: 15119831
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
    Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
    Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronary risk factors, endothelial function, and atherosclerosis: a review.
    Vogel RA
    Clin Cardiol; 1997 May; 20(5):426-32. PubMed ID: 9134272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipoproteins and the haemostatic system in atherothrombotic disorders.
    Miller GJ
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):555-75. PubMed ID: 10856985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endothelium, fibrinolysis, cardiac risk factors, and prostaglandins: a unified model of atherogenesis.
    Kadish J
    Med Hypotheses; 1995 Aug; 45(2):205-13. PubMed ID: 8531844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.